EUVIMEDEUVIMED entdecken
Crossref

Quinazoline derivatives inhibit cell growth of prostate cancer as a WRN helicase dependent manner by regulating DNA damage repair and microsatellite instability

Jia Yu, Yunyun Zhou, Guangyan Liang, Sha Cheng, Jiaomei Wei, Huimin Li, Xinyu Liu, Chang You, Mengsha Mao, Mashaal Ahmad, Gang Yu, Bixue Xu und 1 weitere

Bioorganic Chemistry · 2024-12 · 153 · 107963

DOI: 10.1016/j.bioorg.2024.107963 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2024-12. Verfasst von Jia Yu und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China; Natural Products Research …. Hauptthemen laut MEDLINE: Werner Syndrome Helicase, Cell Proliferation, Prostatic Neoplasms, Quinazolines. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

WRN helicase is a crucial target of synthetic death in cancer and has a unique advantage in the treatment of microsatellite unstable cancers. Our previous studies have found that quinazoline derivatives showed the WRN-dependent antiproliferative activity. In this study, a series of new quinazoline derivatives were designed and synthesized by optimizing the structure, and evaluating the targeting and sensitivity to WRN helicase. Cell growth inhibition experiments on WRN overexpressing PC3 cells (PC3-WRN) showed that the antiproliferative activity of some compounds was significantly dependent on WRN helicase. Moreover, the antitumor activity of 9in vivo was significantly decreased in the nude mouse model constructed with WRN knockdown PC3 cells (PC3-shWRN) compare (P < 0.01) to the control group. The molecular docking and CETSA results showed that 9 directly binds to WRN protein. Mechanism studies have confirmed that 9 targeted WRN, and may affect the binding between WRN and other key regulators, to destroy the repair function and regulate genomic stability. In addition, 9 also has suitable pharmacokinetic parameters and low toxicity in vivo. This result indicates that the quinazoline derivative 9 could be a novel WRN function inhibitor for the treatment of prostate cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Werner Syndrome HelicaseCell ProliferationProstatic NeoplasmsQuinazolinesAntineoplastic AgentsDose-Response Relationship, DrugDNA DamageHumansMaleAnimalsStructure-Activity RelationshipMolecular StructureMiceDrug Screening Assays, AntitumorDNA RepairMice, NudeMolecular Docking SimulationCell Line, TumorNeoplasms, Experimental

Stichwörter der Autor:innen

DNA damage repairMicrosatellite instabilityProstate cancerQuinzoline derivativesWRN Helicase

Substanzen

Werner Syndrome HelicaseQuinazolinesAntineoplastic AgentsWRN protein, human

Autor:innen und Institutionen

  • State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China; Natural Products Research Center of Guizhou Province, Guiyang 550014, China.
  • State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China; Natural Products Research Center of Guizhou Province, Guiyang 550014, China; School of Pharmaceu…
  • State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China; Natural Products Research Center of Guizhou Province, Guiyang 550014, China; College of Pharmacy…
  • State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China.
  • State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China; Natural Products Research Center of Guizhou Province, Guiyang 550014, China. Electronic address:…

Zitieren

APA

Yu, J., Zhou, Y., Liang, G., Cheng, S., Wei, J., Li, H., Liu, X., You, C., Mao, M., Ahmad, M., Yu, G., Xu, B., & Luo, H. (2024). Quinazoline derivatives inhibit cell growth of prostate cancer as a WRN helicase dependent manner by regulating DNA damage repair and microsatellite instability. Bioorganic Chemistry, 153, 107963. https://doi.org/10.1016/j.bioorg.2024.107963

Vancouver

Yu J, Zhou Y, Liang G, Cheng S, Wei J, Li H, et al. Quinazoline derivatives inhibit cell growth of prostate cancer as a WRN helicase dependent manner by regulating DNA damage repair and microsatellite instability. Bioorganic Chemistry. 2024;153:107963. doi:10.1016/j.bioorg.2024.107963

BibTeX
@article{Yu2024,
  author = {Yu, Jia and Zhou, Yunyun and Liang, Guangyan and Cheng, Sha and Wei, Jiaomei and Li, Huimin and Liu, Xinyu and You, Chang and Mao, Mengsha and Ahmad, Mashaal and Yu, Gang and Xu, Bixue and Luo, Heng},
  title = {Quinazoline derivatives inhibit cell growth of prostate cancer as a WRN helicase dependent manner by regulating DNA damage repair and microsatellite instability},
  journal = {Bioorganic Chemistry},
  year = {2024},
  volume = {153},
  pages = {107963},
  doi = {10.1016/j.bioorg.2024.107963}
}
Kostenlos starten →